Patents by Inventor Gongping He

Gongping He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230337647
    Abstract: The present disclosure provides transgenic nematode systems for assessing function of heterologous genes, their variants and drug discovery. The transgenic nematodes contain a heterologous gene that is inserted via homologous recombination at the native locus replacing and removing the nematode ortholog, wherein expression of the heterologous gene rescues function of the removed nematode ortholog and a transgenic control animal is provided. The heterologous gene may be further modified to provide a variant, such as a human clinical variant, whereby a transgenic test animal is provided. Those transgenic test animals are used in methods to assess function of the heterologous variant and drug screens to find therapeutic candidates reversing deviant activity back to wildtype.
    Type: Application
    Filed: September 14, 2022
    Publication date: October 26, 2023
    Applicant: NemaMetrix Inc.
    Inventors: Christopher E. Hopkins, Trisha J. Brock, Kathryn McCormick, Gongping He
  • Patent number: 11477970
    Abstract: The present disclosure provides transgenic nematode systems for assessing function of heterologous genes, their variants and drug discovery. The transgenic nematodes contain a heterologous gene that is inserted via homologous recombination at the native locus replacing and removing the nematode ortholog, wherein expression of the heterologous gene rescues function of the removed nematode ortholog and a transgenic control animal is provided. The heterologous gene may be further modified to provide a variant, such as a human clinical variant, whereby a transgenic test animal is provided. Those transgenic test animals are used in methods to assess function of the heterologous variant and drug screens to find therapeutic candidates reversing deviant activity back to wildtype.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: October 25, 2022
    Assignee: NemaMetrix Inc.
    Inventors: Christopher E. Hopkins, Trisha J. Brock, Kathryn McCormick, Gongping He
  • Publication number: 20200208777
    Abstract: The invention discloses a liquid oxygen storage tank, which includes an outer tank body, a buffer cavity is provided in the outer tank body, and an insulation tank with an upper end extending outside the buffer cavity is provided in the buffer cavity, and the buffer chamber is provided in the buffer tank. There is a buffer mechanism for reducing the impact force of the tank body. The thermal insulation tank is internally provided with an internal tank body, the internal tank body is provided with a storage cavity, and the upper end of the thermal insulation tank is provided with a control cavity. A driving block is arranged in the cavity. The invention adopts a high-vacuum multi-layer thermal insulation technology to prolong the number of days for holding liquid oxygen, and a heat preservation mechanism makes the storage time of liquid oxygen longer, and it is safer and more convenient to operate. If it is too high, it will start automatically and discharge excess gas to enhance the safety of use.
    Type: Application
    Filed: March 12, 2020
    Publication date: July 2, 2020
    Inventor: Gongping He
  • Publication number: 20200060246
    Abstract: The present disclosure provides transgenic nematode systems for assessing function of heterologous genes, their variants and drug discovery. The transgenic nematodes contain a heterologous gene that is inserted via homologous recombination at the native locus replacing and removing the nematode ortholog, wherein expression of the heterologous gene rescues function of the removed nematode ortholog and a transgenic control animal is provided. The heterologous gene may be further modified to provide a variant, such as a human clinical variant, whereby a transgenic test animal is provided. Those transgenic test animals are used in methods to assess function of the heterologous variant and drug screens to find therapeutic candidates reversing deviant activity back to wildtype.
    Type: Application
    Filed: February 21, 2019
    Publication date: February 27, 2020
    Applicant: NemaMetrix Inc.
    Inventors: Christopher E. Hopkins, Trisha J. Brock, Kathryn McCormick, Gongping He
  • Publication number: 20090062229
    Abstract: Methods and compositions for reducing the expression of Rho-associated, coiled-coil containing protein kinase 2 (ROCK-II) are provided.
    Type: Application
    Filed: May 6, 2008
    Publication date: March 5, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Gongping He
  • Patent number: 7371850
    Abstract: Methods and pharmaceutical compositions for treating, and delaying the onset of, viral infection, are provided.
    Type: Grant
    Filed: August 20, 2004
    Date of Patent: May 13, 2008
    Assignee: Myriad Genetics, Inc.
    Inventors: Scott Morham, Gongping He